Benerva 300mg Vitamin B1 20 Gastro-resistant Tablets

Benerva, gastro-resistant tablet drug for oral use is indicated for the treatment of:

Prophylaxis and therapy of vitamin B1 deficiency due to increased demand or reduced absorption (beriberi and its various clinical forms);
Deficient polyneuritis (ethyl);
Myocardiopathies of alcoholics;
In high doses, adjuvant therapy of neuritis and non-deficient polyneuritis.

Dosage and method of use
Benerva should be used in the following ways and posology:

Mild and moderate cases: 100 mg every 24 hours.
Severe cases: 600-1200 mg (2-4 tablets of Benerva of 300 mg) per day for 1-2 weeks, then 300 mg (1 tablet of Benerva of 300 mg) per day for several weeks.

The high-dose Benerva tablets (300 mg) allow for an intensive treatment.

Contraindications

Known individual hypersensitivity to the components of the product.

Special warnings
Preparations based on vitamin B1 or derivatives, especially parenterally, can cause problems in subjects who have had sensitization phenomena or morbid manifestations of allergies. The risk of hypersensitivity reactions is increased with repeated intramuscular administration. Oral administration is therefore preferable where possible.

Pregnancy and breastfeeding
Benerva is not indicated for use during pregnancy or breastfeeding.

Expiration and retention
The expiry date refers to the product in intact packaging, correctly stored.

Warning: do not use the medicine after the expiry date indicated on the package.

Composition
Benerva contains, for each tablet:
Active ingredients: thiamine hydrochloride (vitamin B1) 300 mg
Excipients: talc, povidone K90, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1: 1), macrogol 6000, carmellose sodium.

Benerva 300 mg in packs of 20 tablets